USD 0.01
(133.33%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.67 Million CAD | 2.66% |
2022 | 1.62 Million CAD | -10.29% |
2021 | 1.81 Million CAD | -91.02% |
2020 | 20.2 Million CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | -100.0% |
2006 | 6000.00 CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 1.66 Million CAD | -0.44% |
2023 Q3 | 1.78 Million CAD | 2.26% |
2023 Q4 | 1.67 Million CAD | -6.15% |
2023 Q1 | 1.38 Million CAD | -15.17% |
2023 FY | 1.67 Million CAD | 2.66% |
2023 Q2 | 1.74 Million CAD | 26.09% |
2022 Q2 | 2.52 Million CAD | 35.41% |
2022 Q4 | 1.62 Million CAD | -29.76% |
2022 Q3 | 2.31 Million CAD | -8.06% |
2022 FY | 1.62 Million CAD | -10.29% |
2022 Q1 | 1.86 Million CAD | 2.59% |
2021 FY | 1.81 Million CAD | -91.02% |
2021 Q1 | 9.43 Million CAD | -53.32% |
2021 Q3 | 1.95 Million CAD | -81.89% |
2021 Q4 | 1.81 Million CAD | -7.16% |
2021 Q2 | 10.79 Million CAD | 14.47% |
2020 Q3 | 12.11 Million CAD | -5.18% |
2020 FY | 20.2 Million CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | 12.77 Million CAD | 0.0% |
2020 Q4 | 20.2 Million CAD | 66.87% |
2019 Q4 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2007 Q1 | 6000.00 CAD | 0.0% |
2007 Q2 | 6000.00 CAD | 0.0% |
2007 Q3 | - CAD | -100.0% |
2007 Q4 | - CAD | 0.0% |
2007 FY | - CAD | -100.0% |
2006 FY | 6000.00 CAD | 0.0% |
2006 Q4 | 6000.00 CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | 25.347% |
Arrayit Corporation | 1.07 Million USD | -55.1% |
Atlantic International Corp. | 2.93 Million USD | 42.937% |
Biocept, Inc. | 12.1 Million USD | 86.19% |
Bioqual, Inc. | 3.58 Million USD | 53.38% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -2202.911% |
DermTech, Inc. | 54.39 Million USD | 96.926% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.646% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 65.406% |
iMD Companies, Inc. | 1.12 Million USD | -49.287% |
IDenta Corp. | 789.14 Thousand USD | -111.905% |
Interpace Biosciences, Inc. | 11.19 Million USD | 85.059% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -3713.972% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | 79.214% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | 56.292% |
NovelStem International Corp. | 3.57 Million USD | 53.219% |
Optigenex Inc. | 8.94 Million USD | 81.296% |
PharmChem, Inc. | 77.35 Thousand USD | -2061.824% |
Proteome Sciences plc | 17.15 Million USD | 90.251% |
Response Genetics, Inc | 6.37 Million USD | 73.761% |
Rennova Health, Inc. | 15.32 Million USD | 89.091% |
RushNet, Inc. | 4.82 Million USD | 65.329% |
ScreenPro Security Inc. | 207.03 Thousand USD | -707.711% |
Stella Diagnostics Inc. | 6.2 Million USD | 73.031% |
StageZero Life Sciences Ltd. | 1.8 Million USD | 7.102% |
Todos Medical Ltd. | 38.34 Million USD | 95.639% |